DC Funds, LP — Q2 2024 13F-HR

← DC Funds, LP

Q2 2024 · 13F-HR

DC Funds, LPholdings as filed

Filed 2024-08-13 · accession 0001398344-24-014514

$6.0M

Reported value

Positions

2024-06-30

Period end

View analyzed profile →PRO

Holdings as filed

CUSIP	Ticker	Issuer	Value	% port.	Shares	Class	Voting
89854M101	TCRX	TSCAN THERAPEUTICS INC	$3.7M	61.2%	630,000	Common	SOLE
95075A107	HOWL	WEREWOLF THERAPEUTICS INC	$1.4M	23.9%	589,102	Common	SOLE
91864C107	BRNS	BARINTHUS BIOTHERAPEUTICS PL	$899,086	14.9%	642,204	Common	SOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.